If a case of variant CJD were identified in a blood donor, all components and products would be withdrawn. There was a presentation on the active surveillance project for identifying and investigating all cases of suspected CJD in Canada. In presentations and discussions, Council heard that policy development cannot await definitive scientific data on risks. There always has to be a balance between the possible, potential risk and real risks of blood shortages and increasing known risks. Council heard that among the many factors that have to be considered is the public s loss of faith in the blood system.
Decisions have to be made and the decisions and reasons have to be clearly communicated.
The plans, and process for decision making and dealing with the impact of the decision was described by the blood service organizations. The chair of the donor and volunteer association of Hema Quebec described a donor s perspective and the structure, function and objectives of the newly formed organization. Education and follow-up maybe the essential factors that tip the balance in favour of recipients having the option to be notified. Following questions, answers and discussions, Council made the following recommendations. Donor deferral policies must be coupled with strategies to increase donor recruitment.